Consensus on GI prophylaxis with anti-platelet agents

The ACC/AHA/ACG has issued a consensus statement on the use of GI prophylaxis (primarily PPIs) in patients on anti-platelet agents (primarily ASA and clopidogrel). The summary states that patients at low risk for GI bleeding do not require GI prophylaxis. Risk factors that would require consideration of GI prophylaxis include: multiple agents (anticoagulants, NSAIDs, steroids), advanced age, history of GI bleeding, and HPylori infection. A full copy can be found at (site)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment